ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Genasys secures $1.4M in LRAD orders from Asia-Pacific, Europe

Orders span Australia, Japan, Thailand and European nations for long-range acoustic devices used in naval, coast guard and security operations. CEO cites regional tensions driving demand.

PA
Priya Anand · Equities & Earnings Desk · 19 Aug 2026 · 06:43 · 1 min read
Share
Genasys secures $1.4M in LRAD orders from Asia-Pacific, Europe

Genasys Inc. (NASDAQ: GNSS) said it received approximately $1.4 million in orders for its Long Range Acoustic Devices (LRAD) from customers in the Asia-Pacific region and Europe.

The orders, spanning Australia, Japan, Thailand, Vietnam, Papua New Guinea, Lithuania and Latvia, target naval, coast guard, police and security applications. Chief Executive Officer Richard Danforth attributed the demand to escalating regional tensions, noting that several Asia-Pacific countries are investing in LRAD systems to improve communication, safety and security.

The company stated the orders include both new and follow-on purchases, with management expecting international market momentum to extend through 2027. LRAD systems broadcast audible communications detectable over wind, engine and background noise at distances up to 5,000 meters, supporting ship-to-ship communication, vessel exclusion zones, search and rescue operations, port security and anti-piracy missions.

Genasys said its protective communications solutions are deployed by public safety and defense agencies in more than 100 countries, covering over 155 million people across all 50 U.S. states and in more than 100 countries worldwide.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT